Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
68 Cards in this Set
- Front
- Back
in north america what is the general flow of glaucoma treatment using laser, surgery and medial treatment
|
medical, laser, and then surgery
|
|
aqueous is secreted by what cells
|
the non pimented ciliary epithelium
|
|
using CB, SC space, uveaoscleral outflow, and sclera describe the aqueous outflow
|
uveoscleral outflow --> CB--> SC space --> sclera
|
|
is glaucoma usually associated with an increase in aqueous production or a decrease in outflow.
|
decrease in outflow
|
|
what are the three theories of glaucoma damage? (three ways damage occurs)
|
1. direct mechanical therory where pressure blocks axoplasmic flow
2. ischemic theory where pressure blocks circulation to nerve 3. apoptosis |
|
three main ways of treatment for glaucoma
|
reduce aq. production
increase outflow neuroprotection |
|
name two types of drugs that reduce aq. production and give some examples of each
|
adrenergic antagonists - Beta blockers
carbonic anhydrase inhibitors - dorzolamide, acetazolamide, methazolamide... |
|
what happens when Beta 1 receptors are stimulated?
|
tachycardia and increased cardiac output
|
|
what occurs when beta 2 receptors are stimulated
|
bronchial dilation
|
|
what receptor is involved with negative feedback?
|
alpha 2
|
|
what is the only beta 1 selective beta blocker
|
betaxolol
|
|
what time of day do you not want to have a pt take a beta blocker
|
at night
|
|
betoptic s (betaxolol) is in what form
|
suspention this is the only beta blocker in this form it is less stingy than others
|
|
if a person has a history of asthma what beta blocker would you give them
|
betaxolol b/c it is the only one that is beta 1 selective so it will not affect the lungs as much
|
|
what is the typical dose for a beta blocker?
|
BID, many docs will try qd first
|
|
what is the mechanism of action fro a beta blocker
|
decrease the aqeous production by blocking the beta receptors on the ciliary body
|
|
what percentage do beta blockers drop the iop by usually
|
22 to 33%
|
|
what types of glaucomas are beta blocker used to treat, your choices are POAG, angle closure and secondary
|
all of the above
|
|
list the side effects of beta blockers from most common to least common. 5 of them
|
CNS deprssion, ocular sting/burn, bradycardia, bronchospasm, and aggravate lipid levels/mask hypoglycemia.
|
|
what is the beta blocker that is least likely to cause CNS depression and why
|
carteolol b/c it doesnt cross the blood brain barrier.
|
|
what must you do before you prescribe a pt a beta blocker
|
ALWAYS CHECK BLOOD PRESSURE, PULSE, RESPIRATORY/BLOOD STATUS BEFORE AND DURING TREATMENT AND RECORD
|
|
what are the contraindications for beta blockers
|
bronchial obstruction/asthma
chronic obstructive pulmonary disease bradycardia/congestive heart failure uncontrolled diabetes/hyperlipidemia not in notes but mentioned in lecture was a pt that is already on systemic betablockers |
|
drugs ending in -amide are in what class
|
carbonic anhydrase inhibitors
|
|
CAI's are used by themselves or rarely used by themselves for treatment of glaucoma
|
rarely used by themselves in drop form unless the pt is already on systemic beta blockers
|
|
what is the mechanism of action for CAI's? also do they decrease aqueous production or outflow
|
they inhibit the carbonic anhydrase that is on the non pigmented ciliary epithelium there for decreasing aqueous production
|
|
what percentage of reduction in IOP is seen with CAIs
|
15 to 20%
|
|
what is cosopt what % of reduction in IOP is seen when used
|
combo drug that includes the CAI dorzolamide and timolol. 30 to 35%
|
|
what CAI is in suspension form, what is its benefit
|
brinzolamide (azopt) it has less sting than non suspension forms
|
|
what are the two main systemic CAIs and what are they used for
|
acetazolamide and methazolamide, they are primarily used for emergency situations and are not intended for long term use. note that acetazolamide is cheaper but requires q6hrs as opposed to BID
|
|
a person diagnosed with pseudotumor cerebri would be given what drug to reduce CSF pressure? ...........................hint ........also used for altitude sickness
|
systemic CAIs like acetazolamide (diamox)
|
|
what type of ocular problems that a pt has would make you consider not giving them a CAI
|
if they have a compromised cornea b/c CAIs cause superficial punctate keratitis, ocular allergies, sting and burn and the kicker is endothelial cell function
|
|
what are the ocular side effects of a CAI
|
superficial punctate keratitis, ocular allergies, sting and burn and the kicker is endothelial cell function
|
|
what type of allergies do you need to ask about before giving a CAI
|
sulfa alergies, this is a different form but caution is advised
|
|
what are some of the systemic SE of CAIs
|
loss of appetite, nausia/fatigue, tinnitus, parasthesias in extremities, and electrolyte distubances.
|
|
what are the contraindications for CAIs
|
sulfa alergy
sickle cell anemia or other blood dyscrasias corneal surgery or epithelial/endothelial disease |
|
what drug is essencially epinephrin in a bottle
|
dipivefrin, it really doesnt get converted into epinephrin until it is in tissues and contacts enzymes
|
|
what was the first drop for glaucoma that acted by increasing the outflow and not seen much anymore but may be on boards
|
dipivefrin (propine)
|
|
dipivefrin (propine) is not commonly used as a gluacoma treatment any more and is contraindicated with aphakes and pseudophakes du to increased risk of what
|
cystoid macular edema
|
|
brimonodine, dipivefrin, and apraclonidine are all in what type of class of drugs? (ex. cholinergic agonist)
|
adrenergic agonist
|
|
alpha 2 agonists such as apraclonidine do what to the pupil
|
dilate it
|
|
what is the mechanism of action that apraclonidine is able to lower IOP
|
it causes a decrease in aqueous production and increases uveoscleral outflow
|
|
brimonidine, a glaucoma drug acts on what kind of receptors and lowers IOP by doing what
|
is an alpha 2 agonist and works by decreasing production and increasing outflow.
|
|
what percentage does brimonidine lower IOP
|
25 to 30%
|
|
which drug has a lower chance of causing tachyphylaxis, brimonidine or apraclonidine?
|
brimonindine
|
|
if a pt is alergic to apraclonidine what other adrenergic agonist could you try
|
brimonidine
|
|
what are some contraindications of apraclonidine
|
concomitant use of MAO inhibitors
severe cardiovascular disease low blood pressure/bradycardia |
|
what are the ocular se of apraclonidine
|
eyelid retraction, mydriasis, conjuctival blanching, and 20 to 30% of people are allergic
|
|
what are the contraindications for brimonidine
|
concomitant use of MAOIs
severe cardio dz depresion cerebral or coronary insufficiency |
|
combigan is a combo of what (only in canada)
|
brimonodine and timolol
|
|
what effect does a cholinergic agonist have on the pupil
|
miotic
|
|
what general class is pilocarpine in
|
cholinergic agonist (parasympathometic)
|
|
are concentrations of 4% of pilocarpine more effective in lowering IOP than the regular concentration of .25% to 10%
|
no
|
|
what forms does pilocarpine come in
|
drops, gel and ocuserts
|
|
what is the mechanism of action for pilocarpine
|
it contracts the muscles in the ciliary body stretching the TM increasing the outflow and it also pulls the iris away from the angle to allow outflow
|
|
what is an example of a person that you would not want to use pilocarpine on
|
a person with pre existing retinal dz or high myopia, they have the increased risk of RD
|
|
what type of glaucoma do you NOT want to use pilocarpine on
|
inflammatory or vascular
|
|
if you think that you have an adies tonic pupil what drug and conc. would you use
|
pilocarpine the pupil is not reacting to light but is super sensitive to pilo so use .125% and if you get a reaction it is positive for adies
|
|
pilocarpine and what class of drugs cancel each others IOP effectivness out
|
prostaglandins
|
|
in general what percentage of drop in IOP would you expect from a prostaglandin
|
about 30%
|
|
how does latanoprost (xalatan) work to lower the IOP? increase outflow or decrease production
|
increases the out flow by loosening the intercellular spaces in the ciliary body. (same as latanoprost, and xalatan)
|
|
what may be the single most effective glaucoma medication available
|
bimatoprost (lumigan)
|
|
are there systemic issues with latanoprost (xalatan)
|
none
|
|
what race is it thought that travaprost is more effective
|
African Americans
|
|
what is the mechanism of action that bimatoprost (lumigan) lowers IOP
|
increases the out flow by loosening the intercellular spaces in the ciliary body (same as latanoprost, and xalatan)
|
|
what is the mechanism of action that travaprost (travatan) lowers IOP
|
increases the out flow by loosening the intercellular spaces in the ciliary body (same as latanoprost, and xalatan)
|
|
what side effect is seen with the use of prostaglandins in aphakes/pseudophakes?
|
CME
|
|
what are some of the inflammatory SE that could occur with the use of prostaglandins for glaucoma
|
HSV, uveitis and/or conjunctivitis
|
|
what are some of the contra indications for prostaglandin use for IOP lowering
|
Aphakia/pseudophakia, Hx of uveitis, YAG posterior capsulotomy, Hx of HSV, or if the pt has cosmetic concerns
|